Target intelligence / Profile preview

Peroxisomal fatty acid beta-oxidation enzyme (None universally accepted; individual enzymes have canonical abbreviations (e.g., ACOX1 for acyl-CoA oxidase))

Target
None universally accepted; individual enzymes have canonical abbreviations (e.g., ACOX1 for acyl-CoA oxidase)
Molecular classification
Enzyme, Oxidoreductase (for acyl-CoA oxidase), Hydratase/dehydrogenase (for MFP), Thiolase
01

Overview

Peroxisomal fatty acid beta-oxidation enzymes are a group of enzymes localized in the peroxisome, responsible for the breakdown of very long-chain and branched-chain fatty acids. The process involves multiple enzymatic steps—first, acyl-CoA oxidase oxidizes fatty acyl-CoA substrates, producing hydrogen peroxide. Multifunctional proteins (MFPs) then hydrate and dehydrogenate the substrate, and finally thiolases cleave acetyl-CoA units, progressively shortening the fatty acid chain. This metabolic pathway is critical for energy homeostasis, lipid detoxification, myelin synthesis, and cellular maintenance. Deficiency or dysfunction of these enzymes results in serious metabolic diseases, often with severe neurological and systemic manifestations. The term "Peroxisomal fatty acid beta-oxidation enzyme" refers to a family/class of enzymes rather than a specific protein or receptor. To be structurally precise, the canonical form should specify the individual enzyme (e.g., "Peroxisomal acyl-CoA oxidase") for structured data or drug discovery programs.

Other names
Peroxisomal beta-oxidation enzymesperoxisomal acyl-CoA oxidaseperoxisomal MFP (multifunctional protein)peroxisomal thiolase
02

Mechanism of action

Not drug-targeted directly; disease management typically involves bypassing defective metabolism, dietary controls, or supporting residual function

03

Biological functions

Lipid catabolism (breakdown of fatty acids, especially very long chain and branched-chain fatty acids)Energy homeostasis (generation of acetyl-CoA)Regulation of cellular reactive oxygen species (production and breakdown of hydrogen peroxide)Biosynthesis of plasmalogens and bile acidsCellular detoxification (metabolism of phytanic acid, pristanic acid)
04

Disease associations

Metabolic disorders (e.g., Zellweger syndrome, adrenoleukodystrophy)Neurological disorders (resulting from abnormal myelin lipid synthesis)Cancer (altered peroxisomal function can impact tumor lipid metabolism)Other rare inherited peroxisomal disorders
05

Safety considerations

Loss or defect of peroxisomal beta-oxidation enzymes leads to accumulations of toxic lipids in tissues, damaging the nervous system, liver, and other organsPeroxisomal disorders are often severe and difficult to treat; therapeutic challenge is effective enzyme restoration or metabolic bypass
06

Interacting drugs

No established direct drugs; experimental modulation includes gene therapy, dietary management (e.g., restriction of phytanic acid in Refsum disease), and enzyme replacement
07

Biomarkers

VLCFA plasma levels (very long chain fatty acids)Phytanic acid concentrations (for alpha-oxidation disorders)Peroxisomal enzyme activities (diagnostic enzymology)

Beyond the preview

Go deeper on Peroxisomal fatty acid beta-oxidation enzyme (None universally accepted; individual enzymes have canonical abbreviations (e.g., ACOX1 for acyl-CoA oxidase)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxisomal fatty acid beta-oxidation enzyme (None universally accepted; individual enzymes have canonical abbreviations (e.g., ACOX1 for acyl-CoA oxidase)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call